Softgel Capsules Market : Global Industry Analysis and Opportunity Assessment, 2035

Softgel Capsules Market Size, Market Forecast and Outlook By FMI

The market is anticipated to expand from USD 1,245.3 million in 2025 to USD 2,209.2 million by 2035. Gelatin-based capsules retain dominance due to their biocompatibility, versatility, and regulatory acceptance. The growth is supported by rising demand for nutraceuticals, personalized medicine, and plant-based alternatives, along with increasing chronic disease prevalence. Manufacturers are investing in high-throughput encapsulation technologies, clean-label ingredients, and advanced formulations to meet regulatory and consumer expectations.

Summary of Softgel Capsules Market

• Demand and Growth Drivers
  • Growing preference for oral drug delivery systems due to ease of administration and improved bioavailability.
  • Increasing use of nutraceuticals, vitamins, herbal supplements, and disease-specific formulations.
  • Technological innovations in encapsulation and personalized dosage are expanding applications.
• Product and Segment View
  • Gelatin-based softgels dominate due to stability, versatility, and cost-effectiveness.
  • Type A Gelatin leads raw materials owing to excellent gelation properties and regulatory acceptance.
  • Vegetarian and plant-based alternatives are gaining traction for clean-label and dietary requirements.
• Geography and Competitive Outlook
  • North America leads demand due to high consumer awareness and nutraceutical adoption.
  • Europe is growing with functional nutrition trends and high regulatory compliance.
  • Asia Pacific is expanding rapidly, driven by emerging markets like India, China, Japan, and South Korea.
  • Major players include Catalent Inc., Aenova Group, Fuji Capsule Co., EuroCaps Ltd., Captek Softgel International Inc., Soft Gel Technologies Inc., and Procaps Group.
• Analyst Opinion
  • Sabyasachi Ghosh, Principal Consultant at FMI, notes, “Softgel capsules are evolving from traditional gelatin-based formulations toward plant-based and personalized solutions, driven by health-conscious consumers and nutraceutical innovation.”
• Softgel Capsules Market Value Analysis
  • Gelatin-based capsules provide superior bioavailability and are widely accepted across pharmaceutical and nutraceutical sectors.
  • Type A Gelatin remains the preferred raw material for versatility and rapid dissolution properties.
  • Plant-based softgels and controlled-release systems create new opportunities in functional and personalized nutrition.
  • Asia Pacific is emerging as a high-growth region due to rising health awareness and manufacturing expansion.

Analyzing Softgel Capsules Market by Top Investment Segments

Gelatin-Based Softgel Capsules Lead the Market Due to Biocompatibility, Stability, and Versatility

In 2025, gelatin-based softgel capsules are projected to capture 73.1% of the total revenue share in the softgel capsule market. This dominance is driven by the well-established benefits of gelatin as a versatile, biocompatible material that provides excellent stability and ease of manufacturing. Gelatin capsules are widely preferred in the pharmaceutical and nutraceutical industries due to their ability to encapsulate a variety of active ingredients, including oils, powders, and liquids, with high bioavailability.

Additionally, gelatin-based softgel capsules are cost-effective to produce and widely accepted by regulatory bodies, further bolstering their market share. The segment’s growth is also attributed to increasing consumer demand for dietary supplements, particularly those related to health, wellness, and aging, where gelatin-based capsules are a preferred format due to their ability to deliver a wide range of active ingredients in a single dosage form.

Type A Gelatin Dominates the Raw Material Segment Due to Excellent Gelation and Versatility in Softgel Capsule Production

In 2025, Type A gelatin is expected to hold 42.0% of the revenue share in the raw material segment of the softgel capsule market. This leading position is due to Type A gelatin’s superior gelation properties, which provide excellent film formation, elasticity, and strength in softgel capsule production. Derived from pork skin, Type A gelatin is highly favored for its ability to dissolve efficiently and release active ingredients rapidly in the gastrointestinal tract, making it ideal for pharmaceutical and nutraceutical applications.

Its versatility in encapsulating both hydrophilic and lipophilic ingredients has further contributed to its widespread adoption in the production of softgel capsules. Additionally, Type A gelatin has been widely recognized for its cost-effectiveness, availability, and regulatory acceptance, making it the preferred raw material for manufacturers. As the demand for softgel capsules in the global pharmaceutical and dietary supplement industries continues to rise, Type A gelatin is expected to remain the dominant raw material in the market.

Challenges and Opportunities

Challenge: High Production Costs and Material Sensitivities

In contrast, softgels need the use of specialized encapsulation machinery, stringent temperature and humidity controls, and a high degree of precision with gelatin or plant-based polymers. These challenging conditions result in higher operational costs, hence contract manufacturing and in-house production become on the capital-intensive side.

Moreover, softgels are sensitive to moisture, oxygen, and heat, which can cause product instability especially in design nutraceuticals or pharmaceuticals containing volatile oils, live probiotics, or lipid-soluble compounds. The growing number of vegetarian diets worldwide, for example, poses an additional challenge to the softgel form, as gelatin is unsuitable for certain consumer bases (e.g. vegetarians, vegans, and certain religious populations).

Opportunity: Growth in Nutraceuticals, Personalized Dosing, and Plant-Based Alternatives

Despite these limitations, the global softgel capsules market is expected to witness significant growth due to the rising demand for nutraceuticals, omega-3 dietary supplements, herbal extracts, and disease-specific formulations. It provides many benefits, such as convenient swallowing, fast bioavailability, and higher stability of oil-based compounds. Softgels are preferred by consumers for vitamins, anti-inflammatory blends, joint support and cognitive health, driving demand for end-users of all ages.

Vegetarian softgel shells contain tapioca starch, carrageenan or modified cellulose, which has given rise to plant-based supplement brands. In medicine, they are increasingly being used in controlled-release systems, pediatric formulations, and hormonal therapies due to their customizable dosage and taste-masking capabilities.

Country-Wise Outlook

United States

The USA softgel capsules industry is rising consistently due to growing need for dietary supplements along with aging population and growing preference for easy-to-swallow dosage forms. Softgels are commonly used for vitamins, fish oils and prescription drugs, with very high consumer acceptance in OTC and pharmaceutical markets.

Innovation in ways to use gelatin alternatives, controlled-release technologies and bioavailability enhancement are also pepping up. Increased growth in the direct-to-consumer nutraceutical sector in addition to solid retail distribution are also factors in the expanding market.

Country	CAGR (2025 to 2035)
USA	6.0%

United Kingdom

The UK softgel capsules market has been witnessing steady growth over the years, fueled by rising health consciousness among consumers, new opportunities in plant-based supplement trends, and advancements in functional nutrition. Softgels are the preferred form of omega-3, turmeric, and vitamin D supplementation, especially for joint health, immunity, and beauty applications.

To fulfil a gradually increasing customer base of vegetarians and halal consumers, brands are providing vegan and gelatine-free softgel choices. It is also a recommendation-driven market and e-commerce driven channel, with significant growth of personalized wellness products.

Country	CAGR (2025 to 2035)
UK	5.5%

European Union

The European Union softgel capsules market is poised for market expansion, driven by increased demand for high-absorption nutritional supplements, management of chronic diseases, and better regulation of nutritional products. It is due to this factor that Germany, Italy and the Netherlands is dominating in the production as well as consumption of nutraceutical and pharma-grade softgels.

As demand for clean-label, allergen-free and non-GMO supplements grows, softgel innovations, like plant-based and starch-based gel technologies, are also being developed by EU manufacturers. Because of higher bioavailability, pharmaceutical companies are utilizing softgels for hormone therapy, cardiovascular drugs, and central nervous system (CNS) treatments.

Region	CAGR (2025 to 2035)
European Union	5.8%

Japan

Japan is experiencing moderate growth in its softgel capsules market, with the demand being led by its aging population, which prefers easy dosing formats and precise dosing, alongside a focus on wellness and health. Softgels are a popular delivery method in dosage forms that support eye health, energy, and cognitive function, and they are keenly focused on quality and efficacy.

At the same time, local pharmaceutical companies follow developments in customized softgel formulations for niche indications, and nutraceutical companies take advantage of their ability to combine coenzyme Q10 and lutein with collagen in softgel formats. Regulation promotes innovation and protects consumers.

Country	CAGR (2025 to 2035)
Japan	5.4%

South Korea

Growth of the South Korean softgel capsules market is thriving thanks to the wellness trends along with cosmetic-nutritional crossovers and tech-driven supplement delivery. Softgels for skin-care, weight management, and anti-fatigue formulations are gaining popularity among consumers, who are heavily swayed by beauty and wellness influencers.

And domestically, brands are launching sugar-free, fast-dissolving, and plant-based softgel capsules aimed at young, urban consumers. Healthcare segment growth is also being compounded by booming pharmaceutical demand for precision-dose softgels in oncology and chronic care.

Country	CAGR (2025 to 2035)
South Korea	6.1%

Competitive Outlook

The global softgel capsules products market enables consumers to attain a broad spectrum of physical and psychological wellness for longer and is one of the most promising and dynamic segments of the pharma industry. Softgels are popular not just for vitamins and supplements but omega-3s and prescription drugs as well, while providing protection to lipid-based and sensitive formulations.

Major players have their eyes set on gelatin and plant-based alternatives, high-throughput encapsulation, clean-label ingredients, and tailored release profiles. The market consists of CDMOs, pharma companies and dietary supplement manufacturers in therapeutic, preventive and wellness sectors worldwide.

Key Developments:

• In 2024, Roquette, a leader in plant-based ingredients, has launched LYCAGEL® Flex, a new hydroxypropyl pea starch premix. This plasticizer-free excipient for nutraceutical and pharmaceutical softgel capsules allows manufacturers to customize formulations. It aims to set new standards for quality, stability, and performance in plant-based softgels, building on Roquette's existing LYCAGEL® technology
• In 2024, Torque Pharma has introduced Multipower Soft Gelatin Capsules, a new nutraceutical combining multivitamins and essential minerals. This innovation aims to boost immunity and energy, addressing daily nutritional needs. The capsules contain Ginseng extract alongside vital vitamins (A, B1, B2, B6, B12, C, E, B3) and minerals (calcium, copper, iodine, iron, manganese, zinc) to combat deficiencies

Key Players

• Aenova Group
• Fuji Capsule Co., Ltd
• Catalent, Inc
• EuroCaps Ltd
• Guangdong Yichao Biotechnology Co., Ltd.
• Captek Softgel International Inc
• Soft Gel Technologies Inc.
• Thermo Fisher Scientific Inc (Patheon)
• Delpharm Evreux
• Curtis Health Caps
• Sirio Pharma Company Limited
• Elnova Pharma
• United Labs
• Hunan Er-Kang Pharmaceutical Co., Ltd
• Procaps Group (Softigel)
• Softgel Healthcare
• Medgel Pvt. Ltd

Top Segments Studied in the Softgel Capsules Market Research Report

By Product:

• Gelatin Softgel Capsules
• Vegetarian Softgel Capsules

By Raw Material:

• Type-A Gelatin (Pork Skin)
• Type-B Gelatin (Animal Bones & Skin)
• Fish Bone Gelatin
• Cellulose Derivatives
• Starch Material

By Application:

• Antacid & Antiflatulent Preparations
• Antianemic Preparations Hematinic Preparations)
• Anti-inflammatory Drugs
• Antibiotic & Antibacterial Drugs
• Cough & Cold Preparations
• Cardiovascular Therapy Drugs
• Health Supplements
• Vitamin & Dietary Supplements
• Other Therapeutic Applications

By End User:

• In-house Manufacturing
• Contract Manufacturing Organizations

By Route of Administration:

• Oral Softgels
• Suppositories
• Pessaries
• Twist off Softgels
• Others

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• East Asia
• South Asia Pacific
• Middle East and Africa